AI scribes are flooding healthcare, but the real story isn't efficiency—it's data capture and physician burnout transfer. Analyze the hidden costs.
The shift from 'Dr. Google' to 'ChatGPT Health' isn't just an upgrade; it's a hostile takeover of medical self-diagnosis. Who truly profits?
Anthropic is pushing Claude into life sciences, but the real story isn't better diagnoses—it's who controls the new medical intelligence bottleneck.
Anthropic is pushing Claude into healthcare, but the real battle isn't clinical success; it’s controlling the future of proprietary medical data.
OpenAI’s ChatGPT Health launch is here. But beyond the hype, this move signals a massive power shift in medical AI, threatening independent practitioners.
Google's sudden halt on AI health summaries isn't about minor safety bugs; it's a calculated retreat from catastrophic legal exposure in the high-stakes world of digital health.
OpenAI's entry into healthcare isn't about better diagnoses; it's a calculated move to shift medical accountability. We analyze the real winners and losers in this AI power grab.
The British Heart Foundation's £10m data science push is great PR, but the real story in **cardiovascular research** funding is data ownership and privatization.
Forget the hype around the 10 major 2025 health discoveries. The real story is the centralization of power and the death of personalized medicine.
New Afrobarometer data shows collapsing trust in basic health care. This isn't just incompetence; it's a structural failure benefiting the private elite.
The persistent error rate in medical AI isn't a bug; it's a feature of the system. Discover who profits from this calculated risk in healthcare.
Trump's move against state AI laws isn't about patient safety; it's a regulatory land grab that benefits Big Tech and stalls crucial health AI adoption.